EA017393B1 - Производные тиадиазинона - Google Patents

Производные тиадиазинона Download PDF

Info

Publication number
EA017393B1
EA017393B1 EA201000364A EA201000364A EA017393B1 EA 017393 B1 EA017393 B1 EA 017393B1 EA 201000364 A EA201000364 A EA 201000364A EA 201000364 A EA201000364 A EA 201000364A EA 017393 B1 EA017393 B1 EA 017393B1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
formula
thiadiazin
benzyl
dihydro
Prior art date
Application number
EA201000364A
Other languages
English (en)
Russian (ru)
Other versions
EA201000364A1 (ru
Inventor
Оливер Шадт
Дитер Дорш
Франк Штибер
Андре Блаукат
Original Assignee
Мерк Патент Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Патент Гмбх filed Critical Мерк Патент Гмбх
Publication of EA201000364A1 publication Critical patent/EA201000364A1/ru
Publication of EA017393B1 publication Critical patent/EA017393B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EA201000364A 2007-08-30 2008-08-06 Производные тиадиазинона EA017393B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007041115A DE102007041115A1 (de) 2007-08-30 2007-08-30 Thiadiazinonderivate
PCT/EP2008/006466 WO2009030333A1 (de) 2007-08-30 2008-08-06 Thiadiazinonderivate

Publications (2)

Publication Number Publication Date
EA201000364A1 EA201000364A1 (ru) 2010-08-30
EA017393B1 true EA017393B1 (ru) 2012-12-28

Family

ID=39952448

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201000364A EA017393B1 (ru) 2007-08-30 2008-08-06 Производные тиадиазинона

Country Status (16)

Country Link
US (1) US8211886B2 (cg-RX-API-DMAC7.html)
EP (1) EP2181111B1 (cg-RX-API-DMAC7.html)
JP (1) JP5524840B2 (cg-RX-API-DMAC7.html)
KR (1) KR20100065171A (cg-RX-API-DMAC7.html)
CN (1) CN101784544B (cg-RX-API-DMAC7.html)
AR (1) AR068130A1 (cg-RX-API-DMAC7.html)
AU (1) AU2008295193B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0816058A2 (cg-RX-API-DMAC7.html)
CA (1) CA2698062C (cg-RX-API-DMAC7.html)
DE (1) DE102007041115A1 (cg-RX-API-DMAC7.html)
EA (1) EA017393B1 (cg-RX-API-DMAC7.html)
ES (1) ES2426356T3 (cg-RX-API-DMAC7.html)
IL (1) IL204127A (cg-RX-API-DMAC7.html)
MX (1) MX2010002096A (cg-RX-API-DMAC7.html)
WO (1) WO2009030333A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201002218B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2588107A1 (en) 2010-07-01 2013-05-08 Takeda Pharmaceutical Company Limited COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET
EP3229836B1 (en) 2014-12-09 2019-11-13 Institut National de la Sante et de la Recherche Medicale (INSERM) Human monoclonal antibodies against axl
WO2016135041A1 (en) 2015-02-26 2016-09-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Fusion proteins and antibodies comprising thereof for promoting apoptosis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0618201A1 (de) * 1993-04-01 1994-10-05 MERCK PATENT GmbH Thiadiazinone und ihre verwendung zur Bekämpfung von Cardiovaskulären sowie asthmatischen erkrankkungen
WO2007057092A1 (de) * 2005-11-21 2007-05-24 Merck Patent Gmbh Substituierte 5-phenyl-3,6-dihydro-2-oxo-6h-[1,3,4]thiadiazine
WO2007057093A1 (de) * 2005-11-21 2007-05-24 Merck Patent Gmbh 3, 6-dihydro-2-oxo-6h-(1,3,4)thiadiazinderivate

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5795964A (en) 1980-12-04 1982-06-15 Morishita Seiyaku Kk Preparation of 2-substituted-3(2h)-pyridazinone derivative
US4397854A (en) 1981-05-14 1983-08-09 Warner-Lambert Company Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
AU691673B2 (en) 1994-11-14 1998-05-21 Dow Agrosciences Llc Pyridazinones and their use as fungicides
US5635494A (en) 1995-04-21 1997-06-03 Rohm And Haas Company Dihydropyridazinones and pyridazinones and their use as fungicides and insecticides
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
DE19604388A1 (de) 1996-02-07 1997-08-14 Merck Patent Gmbh Arylalkyl-diazinone
CA2242425C (en) 1996-02-13 2006-07-18 Zeneca Limited Quinazoline derivatives as vegf inhibitors
NZ331191A (en) 1996-03-05 2000-03-27 Zeneca Ltd 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
BR9813998A (pt) 1997-11-19 2000-09-26 Kowa Co Novos derivados de piridazina e produtos medicinais contendo os mesmos como ingredientes efetivos
TWI241295B (en) 1998-03-02 2005-10-11 Kowa Co Pyridazine derivative and medicine containing the same as effect component
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
BR0111230A (pt) 2000-05-31 2003-06-10 Astrazeneca Ab Composto, e, uso e processo para a preparação do mesmo
KR20030014425A (ko) 2000-07-07 2003-02-17 앤지오젠 파마슈티칼스 리미티드 혈관 손상제인 콜치놀 유도체
EE200300015A (et) 2000-07-07 2004-10-15 Angiogene Pharmaceuticals Limited Kolhinooli derivaadid kui angiogeneesi inhibiitorid
MXPA04003668A (es) 2001-10-31 2004-07-22 Merck Patent Gmbh Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
DE102006037478A1 (de) * 2006-08-10 2008-02-14 Merck Patent Gmbh 2-(Heterocyclylbenzyl)-pyridazinonderivate
DE102007032507A1 (de) * 2007-07-12 2009-04-02 Merck Patent Gmbh Pyridazinonderivate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0618201A1 (de) * 1993-04-01 1994-10-05 MERCK PATENT GmbH Thiadiazinone und ihre verwendung zur Bekämpfung von Cardiovaskulären sowie asthmatischen erkrankkungen
WO2007057092A1 (de) * 2005-11-21 2007-05-24 Merck Patent Gmbh Substituierte 5-phenyl-3,6-dihydro-2-oxo-6h-[1,3,4]thiadiazine
WO2007057093A1 (de) * 2005-11-21 2007-05-24 Merck Patent Gmbh 3, 6-dihydro-2-oxo-6h-(1,3,4)thiadiazinderivate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CUI J.J.: "Inhibitors targeting hepatocyte growth factor receptor and their potential therapeutic applications", EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, GB, vol. 17, no. 9, 1 September 2007 (2007-09-01), pages 1035-1045, XP002502367, the whole document *

Also Published As

Publication number Publication date
KR20100065171A (ko) 2010-06-15
DE102007041115A1 (de) 2009-03-05
JP2010536896A (ja) 2010-12-02
EP2181111B1 (de) 2013-06-26
AU2008295193A1 (en) 2009-03-12
JP5524840B2 (ja) 2014-06-18
US20100311733A1 (en) 2010-12-09
CA2698062C (en) 2016-05-31
MX2010002096A (es) 2010-03-26
BRPI0816058A2 (pt) 2015-03-31
CN101784544A (zh) 2010-07-21
EP2181111A1 (de) 2010-05-05
IL204127A (en) 2013-08-29
WO2009030333A1 (de) 2009-03-12
ZA201002218B (en) 2010-12-29
HK1146276A1 (en) 2011-05-20
US8211886B2 (en) 2012-07-03
ES2426356T3 (es) 2013-10-22
AU2008295193B2 (en) 2013-04-18
AR068130A1 (es) 2009-11-04
EA201000364A1 (ru) 2010-08-30
CA2698062A1 (en) 2009-03-12
CN101784544B (zh) 2012-08-29

Similar Documents

Publication Publication Date Title
CN101687857B (zh) 嘧啶基哒嗪酮衍生物
EA021362B1 (ru) ПРОИЗВОДНЫЕ 2-БЕНЗИЛПИРИДАЗИНОНА В КАЧЕСТВЕ ИНГИБИТОРОВ Мet КИНАЗЫ
EP2150551B1 (de) 2-oxo-3-benzyl-benzoxazol-2-one derivate und verwandte verbindungen als met-kinase inhibitoren zur behandlung von tumoren
EA014667B1 (ru) Производные пиридазинона для лечения опухолей
EA019322B1 (ru) Производные пиридазинона
EA019534B1 (ru) ПРОИЗВОДНЫЕ 3-(3-ПИРИМИДИН-2-ИЛБЕНЗИЛ)-1,2,4-ТРИАЗОЛО[4,3-b]ПИРИДАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ Met КИНАЗЫ
DE102007025718A1 (de) Pyridazinonderivate
EP2310013A1 (de) Bicyclische triazolderivate zur behandlung von tumoren
IL191361A (en) Compounds Containing 6,3-Dihydro-2-Oxo-H6- [1,3,4] Thyadiazines
EA021067B1 (ru) Производные бензотиазолона
EA015352B1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-2h-1,3,4-тиадиазины
CN101784544B (zh) 噻二嗪酮衍生物
EA020574B1 (ru) Производные пиридазинона для применения в лечении заболеваний, индуцированных киназой
EP2367827A1 (de) 3-(3-pyrimidin-2-yl-benzyl)- ý1,2,4¨triazolo ý4,3-b¨pyridazin-derivate
HK1142891B (en) Pyrimidinyl pyridazinone derivates
HK1146276B (en) Thiadiazinone derivatives
HK1156312A (en) Pyridazinone derivatives

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU